Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Biotechnology

Healthcare
$39.15 +8.79%

+$2.32 today

Market cap
$1.83B
Beta
0.00
52W Low $23.00High $36.61

Volume 0.30M

Average 0.34M

COAG EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How COAG compares with its peers on the latest reported figures

COAG Competitors Peer median
EBITDA Margin for COAG and competitors
Company Period LTM level YoY 3-year change
QUREuniQure N.V.LTM Mar 2026-713.8% -30.6 pp-622.8 pp
RLYBRallybio CorporationLTM Mar 2026-3270.4% +2655.9 pp—
COAGHemab Therapeutics Holdings, Inc. Common StockFY2025— ——
IRONDisc Medicine, Inc.FY2025— ——
DMRADamora Therapeutics, Inc.FY2025— ——
Peer median (excluding COAG) -1992.1%+1312.7 pp-622.8 pp

Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Intrinsic Alpha fair value

Locked

Current Price

$39.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.